Arteria-cerebri-Aneurysma, Sepsis und miliare Lungenrundherde bei einer 32-jährigen Patientin.
- Published in:
- Medizinische Klinik (Urban & Vogel), 2005, v. 100, n. 11, p. 740, doi. 10.1007/s00063-005-1101-6
- By:
- Publication type:
- Article
Works matching AU Lentini, Silvia
Results: 9
1
2
Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF–PH inhibitor for the treatment of renal anaemia.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 2, p. 185, doi. 10.1007/s00228-019-02813-y
- By:
- Publication type:
- Article
3
Drug‐drug interaction of atazanavir on UGT1A1‐mediated glucuronidation of molidustat in human.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 3, p. 511, doi. 10.1111/bcpt.13538
- By:
- Publication type:
- Article
4
Absorption, distribution, metabolism and excretion of molidustat in healthy participants.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2020, v. 127, n. 3, p. 221, doi. 10.1111/bcpt.13409
- By:
- Publication type:
- Article
5
Pseudomembranous and obstructive Aspergillus tracheobronchitis – optimal diagnostic strategy and outcome.
- Published in:
- Mycoses, 2006, v. 49, n. 1, p. 37, doi. 10.1111/j.1439-0507.2005.01180.x
- By:
- Publication type:
- Article
6
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals With Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 488, doi. 10.1002/cpdd.263
- By:
- Publication type:
- Article
7
Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 333, doi. 10.1002/cpt.1571
- By:
- Publication type:
- Article
8
Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies.
- Published in:
- Fundamental & Clinical Pharmacology, 2016, v. 30, n. 2, p. 172, doi. 10.1111/fcp.12170
- By:
- Publication type:
- Article
9
CPAP Results in a Sustained Decrease of NT-Pro BNP in Normotensive and Hypertensive Patients with Obstructive Sleep Apnoea Syndrome.
- Published in:
- Somnologie, 2006, v. 10, n. 1, p. 10, doi. 10.1111/j.1439-054X.2006.00080.x
- By:
- Publication type:
- Article